Results 1 to 10 of about 139,397 (52)

Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis

Frontiers in Cardiovascular Medicine, 2022
Lipoprotein(a) (Lp[a]) blood levels >50 mg/dL is a major cardiovascular disease risk factor in humans. Lp(a) associates with increased cardiovascular calcification, a critical pathology with no clinically available drug therapies.
Maximillian A. Rogers, Samantha K. Atkins, Kang H. Zheng, Kang H. Zheng, Sasha A. Singh, Sarvesh Chelvanambi, Tan H. Pham, Shiori Kuraoka, Erik S. G. Stroes, Masanori Aikawa, Masanori Aikawa, Elena Aikawa, Elena Aikawa   +12 more
doaj   +1 more source

Massive hemoptysis treated with embolization of an ectopic bronchial artery arising from the right thyrocervical trunk: a case report

CVIR Endovascular, 2022
Background Ectopic bronchial artery and non-bronchial systemic arteries may be the culprit vessels of hemoptysis. The main cause of clinical failure of bronchial artery embolization is incomplete embolization caused by the misidentification of the ...
Songhyon Cho, Kenji Kubota, Yoshikazu Hirose, Norihiko Yoshimura, Yui Murai, Yasuo Hirose   +5 more
doaj   +1 more source

Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis

Frontiers in Cardiovascular Medicine, 2022
Cardiac sarcoidosis (CS) is an increasingly recognized cause of heart failure and arrhythmia. Historically challenging to identify, particularly in the absence of extracardiac sarcoidosis, diagnosis of CS has improved with advancements in cardiac imaging.
Alison L. Wand, Jonathan Chrispin, Elie Saad, Monica Mukherjee, Allison G. Hays, Nisha A. Gilotra   +5 more
doaj   +1 more source

Differential Diagnosis Between Psychogenic Pseudosyncope and Vasovagal Syncope in Children: A Quantitative Scoring Model Based on Clinical Manifestations

Frontiers in Cardiovascular Medicine, 2022
The study was designed to explore a clinical manifestation-based quantitative scoring model to assist the differentiation between psychogenic pseudosyncope (PPS) and vasovagal syncope (VVS) in children.
Changjian Li, Changjian Li, Yong Zhang, Ying Liao, Lu Han, Qingyou Zhang, Jia Fu, Dan Zhou, Shuai Long, Hong Tian, Hongfang Jin, Junbao Du, Junbao Du   +12 more
doaj   +1 more source

Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: a pilot randomized controlled trial

BMC Cardiovascular Disorders, 2022
Background Intravenous adenosine is the recommended treatment for paroxysmal supraventricular tachycardia (PSVT). There is no official recommended method of giving adenosine.
Phruek Daengbubpha, Borwon Wittayachamnankul, Krongkarn Sutham, Boriboon Chenthanakij, Theerapon Tangsuwanaruk   +4 more
doaj   +1 more source

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target

Cardiovascular Diabetology, 2022
Background HbA1c variability has emerged as risk factor for cardiovascular diseases in diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects within the recommended HbA1c target has been relatively unexplored.
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Stefan Franzén, Ann-Marie Svensson, Björn Eliasson, Antonio Nicolucci   +7 more
doaj   +1 more source

AI in Cardiac Imaging: A UK-Based Perspective on Addressing the Ethical, Social, and Political Challenges

Frontiers in Cardiovascular Medicine, 2020
Imaging and cardiology are the healthcare domains which have seen the greatest number of FDA approvals for novel data-driven technologies, such as artificial intelligence, in recent years. The increasing use of such data-driven technologies in healthcare
Matthew E. Fenech, Olly Buston
doaj   +1 more source

In‐hospital ventricular arrhythmia in heart failure patients: 7 year follow‐up of the multi‐centric HEARTS registry

ESC Heart Failure, 2019
Aims The aim of this study was to determine the incidence, predictors, and short‐term and long‐term outcomes associated with in‐hospital sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) collectively termed ventricular arrhythmia ...
Basel Alenazy, Shabana Tharkar, Tarek Kashour, Khalid Faiz Alhabib, Hussam Alfaleh, Ahmad Hersi   +5 more
doaj   +1 more source

The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery

BMC Cardiovascular Disorders, 2022
Background and aims Inflammation plays a key role in the initiation and progression of atrial fibrillation (AF). The systemic inflammation indexes are easily evaluated and predict AF development.
Yu Luo, Jian Zhang, Tao Liu, Zongtao Yin, Yan Jin, Jinsong Han, Zhipeng Guo, Huishan Wang   +7 more
doaj   +1 more source

Silent left ventricular apical ballooning and Takotsubo cardiomyopathy in an Australian intensive care unit

ESC Heart Failure, 2019
Aims Recent reports have shown a high incidence of silent left ventricular apical ballooning (LVAB) in the intensive care unit (ICU) setting with potential implications for safe use of inotropes and vasopressors.
Alexandra C. Rowell, Wade G. Stedman, Pierre F. Janin, Naomi Diel, Michael R. Ward, Sharon M. Kay, Anthony Delaney, Gemma A. Figtree   +7 more
doaj   +1 more source